Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

NCT07134725 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

432

Enrollment

OTHER

Sponsor class

Conditions

COVID - 19

Interventions

BIOLOGICAL: SpiN-Tec MCTI UFMG
OTHER: Active Comparator: Covishield® vaccine
OTHER: Active Comparator: Comirnaty® vaccine

Sponsor

Federal University of Minas Gerais

Collaborators

[object Object]
[object Object]
[object Object]